Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor

A Poland, P Teitelbaum, E Glover and A Kende

McArdle Laboratory for Cancer Research, University of Wisconsin, Madison 53706.

[125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin ([125I]Cl3DpD), a radiolabeled, isosteric, analogue of 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD), was synthesized and used to study in vivo tissue localization and in vivo tissue binding. Twenty-four hours after the administration of a tracer dose (1 X 10(-10) mol/kg) of [125I] Cl3DpD to C57BL/6J mice, the hepatic concentration of radioactivity was 1-2% of the administered dose, whereas in mice pretreated with TCDD (1 X 10(- 7) mol/kg), the hepatic accumulation of radiolabel was 25-30% of that administered. Liver homogenate from TCDD-treated mice bound 4 to 10 times more [125I]Cl3DpD than homogenate from control mice. The enhancement of in vivo uptake and in vitro tissue binding of [125I]Cl3DpD by TCDD administration was confined to liver and was not observed in other tissues examined, kidney, lung, spleen, small intestines, and muscle. The administration of TCDD to C57BL/6J mice produces dose-related stimulation of in vivo hepatic uptake of [125I]Cl3DpD, binding of radioligand to liver homogenate, and hepatic aryl hydrocarbon hydroxylase activity, with the dose for half-maximal stimulation, ED50, varying from 1.5 to 4.0 x 10(-9) mol/kg. In congenic C57BL/6J (Ahd/Ahd) mice, which express the lower affinity Ah receptor, the ED50 values for all three responses were shifted to approximately 10-fold higher doses. 3,3',4,4',5,5'-Hexabromobiphenyl, a weak agonist for the Ah receptor produced a dose-related stimulation of these three responses in C57BL/6J mice (ED50 values of approximately 5 X 10(-7) mol/kg), but was without effect in C57BL/6J (Ahd/Ahd) mice. Stimulation of vivo hepatic uptake and in vitro liver homogenate binding of [125I]Cl3DpD was produced by administration of Ah agonists, such as 2,3,7,8-tetrachlorodibenzofuran and beta-naphthoflavone, but inactive congeners and other compounds that do not act via the Ah receptor, e.g. phenobarbital and pregnenolone-16 alpha-carbonitrile, did not evoke these effects. Thus, TCDD and other Ah agonists act through the Ah receptor to increase a liver binding species that increases the hepatic uptake of [125I]Cl3DpD in vivo and binding of this radioligand to liver homogenate in vitro.

Volume 36, Issue 1, pp. 121-127, 07/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				D. R. Bell, S. Clode, M. Q. Fan, A. Fernandes, P. M. D. Foster, T. Jiang, G. Loizou, A. MacNicoll, B. G. Miller, M. Rose, et al. Relationships between Tissue Levels of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), mRNAs, and Toxicity in the Developing Male Wistar(Han) Rat Toxicol. Sci., October 1, 2007; 99(2): 591 - 604. [Abstract] [Full Text] [PDF]

				C. P. Curran, K. A. Miller, T. P. Dalton, C. V. Vorhees, M. L. Miller, H. G. Shertzer, and D. W. Nebert Genetic Differences in Lethality of Newborn Mice Treated In Utero with Coplanar versus Non-Coplanar Hexabromobiphenyl Toxicol. Sci., February 1, 2006; 89(2): 454 - 464. [Abstract] [Full Text] [PDF]

				D. F. Staskal, J. J. Diliberto, M. J. DeVito, and L. S. Birnbaum Inhibition of Human and Rat CYP1A2 by TCDD and Dioxin-like Chemicals Toxicol. Sci., April 1, 2005; 84(2): 225 - 231. [Abstract] [Full Text] [PDF]

				T. L. Thomae, E. Glover, and C. A. Bradfield A Maternal Ahr Null Genotype Sensitizes Embryos to Chemical Teratogenesis J. Biol. Chem., July 16, 2004; 279(29): 30189 - 30194. [Abstract] [Full Text] [PDF]

				R. Sarangapani, J. Teeguarden, M. E. Andersen, R. H. Reitz, and K. P. Plotzke Route-Specific Differences in Distribution Characteristics of Octamethylcyclotetrasiloxane in Rats: Analysis Using PBPK Models Toxicol. Sci., January 1, 2003; 71(1): 41 - 52. [Abstract] [Full Text] [PDF]

				J. J. Diliberto, M. J. DeVito, D. G. Ross, and L. S. Birnbaum Subchronic Exposure of [3H]-2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in Female B6C3F1 Mice: Relationship of Steady-State Levels to Disposition and Metabolism Toxicol. Sci., June 1, 2001; 61(2): 241 - 255. [Abstract] [Full Text] [PDF]

				X. Wang, M. J. Santostefano, M. J. DeVito, and L. S. Birnbaum Extrapolation of a PBPK Model for Dioxins across Dosage Regimen, Gender, Strain, and Species Toxicol. Sci., July 1, 2000; 56(1): 49 - 60. [Abstract] [Full Text] [PDF]

				J. J. Schlezinger and J. J. Stegeman Dose and Inducer-Dependent Induction of Cytochrome P450 1A in Endothelia of the Eel, including in the Swimbladder Rete Mirabile, a Model Microvascular Structure Drug Metab. Dispos., June 1, 2000; 28(6): 701 - 708. [Abstract] [Full Text]